ANI Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
ANIP
CUSIP
00182C103
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00182C103 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 12.8% 7/27/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Meridian Venture Partners II GP, L.P. 13D/A
4.8% 8/22/2025
Event 8/21/2025
Millennium Management LLC 13G/A
3.8% 4/10/2025
Event 3/31/2025
Integrated Core Strategies (US) LLC 13G/A
0.3% 11/13/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 23 99.2 k $7.20 M
2026 Q2 317 25.0 M $1.93 B
2026 Q1 290 23.4 M $1.80 B
2025 Q4 296 21.2 M $1.67 B
2025 Q3 278 20.6 M $1.88 B
2025 Q2 239 20.0 M $1.31 B
2025 Q1 238 20.0 M $1.35 B
2024 Q4 210 19.3 M $1.07 B
2024 Q3 214 19.5 M $1.17 B
2024 Q2 209 15.6 M $993 M
2024 Q1 210 14.8 M $1.03 B
2023 Q4 190 14.1 M $778 M
2023 Q3 193 13.2 M $767 M
2023 Q2 177 12.3 M $662 M
2023 Q1 144 10.5 M $417 M
2022 Q4 133 10.7 M $431 M
2022 Q3 129 10.3 M $330 M
2022 Q2 125 9.88 M $293 M
2022 Q1 131 9.21 M $259 M
2021 Q4 143 8.99 M $414 M
2021 Q3 122 7.28 M $239 M
2021 Q2 121 7.21 M $253 M
2021 Q1 111 7.31 M $264 M
2020 Q4 126 7.80 M $227 M
2020 Q3 124 7.31 M $206 M
2020 Q2 142 7.47 M $241 M
2020 Q1 153 7.99 M $325 M
2019 Q4 184 8.22 M $507 M
2019 Q3 209 9.14 M $666 M
2019 Q2 215 8.97 M $738 M
2019 Q1 204 7.72 M $544 M
2018 Q4 180 7.18 M $323 M
2018 Q3 189 7.76 M $438 M
2018 Q2 196 7.36 M $492 M
2018 Q1 190 6.80 M $396 M
2017 Q4 177 6.54 M $422 M
2017 Q3 158 6.41 M $337 M
2017 Q2 165 6.50 M $305 M
2017 Q1 176 6.47 M $321 M
2016 Q4 173 6.28 M $381 M
2016 Q3 184 6.04 M $401 M
2016 Q2 151 5.61 M $313 M
2016 Q1 132 5.81 M $195 M
2015 Q4 132 6.32 M $285 M
2015 Q3 128 6.99 M $280 M
2015 Q2 132 6.49 M $403 M
2015 Q1 134 6.96 M $435 M
2014 Q4 103 5.63 M $317 M
2014 Q3 74 4.54 M $129 M
2014 Q2 83 4.58 M $157 M
2014 Q1 68 3.79 M $118 M